Vertex cystic fibrosis drug misses trial goal, helps some
(Reuters) - Vertex Pharmaceuticals Inc's Kalydeco cystic fibrosis drug failed to meet the main goal of a late-stage study aimed at expanding its use i...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/zmv7WW5ZxCo/story01.htm
No comments:
Post a Comment